Pace and ablate better than drugs in patients with heart failure and atrial fibrillation: lessons from the APAF-CRT mortality trial.
Cecilia LindePublished in: European heart journal (2021)
Keyphrases
- atrial fibrillation
- phase iii
- study protocol
- cardiovascular events
- catheter ablation
- oral anticoagulants
- left atrial
- phase ii
- clinical trial
- cardiac resynchronization therapy
- left atrial appendage
- heart failure
- direct oral anticoagulants
- risk factors
- percutaneous coronary intervention
- open label
- left ventricular
- type diabetes
- drug induced
- acute coronary syndrome
- mitral valve
- venous thromboembolism